查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
多发性骨髓瘤治疗全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1264109

多发性骨髓瘤治疗全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测

Global Multiple Myeloma Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

多发性骨髓瘤与白血病和淋巴瘤一样，是一种起源于骨髓的血液癌症。 在多发性骨髓瘤中，某些白细胞 (WBC) 开始在骨髓中异常生长。 有多种治疗方法可以减缓疾病的进展。 诱导治疗是本病的首选治疗方法。 然后进行干细胞移植 (SCT)。 在干细胞移植中，一台机器取出患者的干细胞并将其冷冻。 然后将细胞移植到患者体内。 还给予化疗，包括阿霉素、alkeran、cytoxan、oncovin、pomalyst、revlimid、talomid 和 velcade 等药物。 蛋白□体抑製剂是多发性骨髓瘤的常见治疗方法，可用于疾病的所有阶段。

市场动态：

随着这种疾病在人群中的流行率增加，预计多发性骨髓瘤药物市场将会增长。 此外，世界上日益严重的老龄化人口肯定会推动多发性骨髓瘤药物市场的发展。 此外，由于新疗法的批准和现有药物的低疗效，预计市场将大幅上涨。

这份研究报告解释了波特的五力模型、市场吸引力分析和价值链分析。 这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。 此外，这些工具还提供了对全球多发性骨髓瘤治疗市场各个部分的全面评估。 多发性骨髓瘤治疗行业的发展和趋势为这项研究提供了一种整体方法。

市场细分：

多发性骨髓瘤治疗市场报告的这一部分提供了国家/地区层面的详细数据，这有助于战略制定者确定目标受众和每种产品或服务的即将到来的机会。支持

按产品类型

  • 化疗
  • 辐射
  • 干细胞移植
  • 其他支持性治疗

由最终用户/应用程序

  • 医院
  • 诊所
  • 其他

按地区分析：

本部分涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲多发性骨髓瘤治疗市场当前和未来的需求。 此外，它还关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 多发性骨髓瘤治疗市场的主要参与者是 Janssen Biotech, Inc.、Bristol-Myers Squibb、Novartis AG、Bristol-Myers Squibb Company、Millennium Pharmaceuticals、Celgene Corporation、Kesios Therapeutics Limited、Amgene, Inc、Genzyme Corporation、Juno Therapeutics。 本节概述了竞争格局，包括各种战略发展，例如主要併购、未来能力、合作伙伴关係、财务概览、联合研究、新产品开发和新产品发布。

内容

第一章前言

  • 报告内容
    • 目的
    • 目标受众
    • USP（独特的销售建议）及其提供的内容
  • 调查范围
  • 调查方法
    • 市场调研流程
    • 市场研究方法

第 2 章执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章多发性骨髓瘤药物 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场製约因素
  • 机会
  • 行业趋势
  • 波特的五力分析
  • 市场吸引力分析
    • 按产品类型
    • 最终用户
    • 按地区

第四章价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料製造商名单
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 市场发展趋势

第 5 章 COVID-19 爆发的影响分析

第 6 章全球多发性骨髓瘤药物市场分析（按产品类型）

  • 摘要：按产品类型
  • 过去和未来的数据
  • 分析：按产品类型
  • 化疗市场：按地区
  • 辐射市场：按地区
  • 干细胞移植市场：按地区
  • 其他支持性护理市场：按地区

第 7 章全球多发性骨髓瘤药物市场分析：按最终用户分类

  • 最终用户总结
  • 过去和未来的数据
  • 最终用户分析
  • 医院市场：按地区
  • 诊所市场：按地区
  • 其他市场：按地区

第 8 章全球多发性骨髓瘤药物市场分析：按地区

  • 区域展望
  • 简介
  • 北美
    • 摘要、实际数据、预测数据
    • 按北美细分
    • 北美：按国家/地区列出
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 摘要、实际数据、预测数据
    • 欧洲（按细分市场）
    • 欧洲：按国家/地区分类
    • 英国
    • 法国
    • 德国
    • 意大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 摘要、实际数据、预测数据
    • 按亚太地区细分
    • 亚太地区：国家/地区信息
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 拉丁美洲
    • 摘要、实际数据、预测数据
    • 拉丁美洲细分市场
    • 拉丁美洲：按国家/地区列出
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲地区
  • 中东和非洲
    • 摘要、实际数据、预测数据
    • 中东和非洲分部信息
    • 中东和非洲：按国家/地区列出
    • 沙特阿拉伯
    • 阿联酋
    • 以色列
    • 南非
    • 其他中东和非洲地区

第9章：多发性骨髓瘤药物公司的竞争格局

  • 多发性骨髓瘤药物市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他扩展

第十章公司简介

  • 公司股票分析
  • 市场集中度
  • 杨森生物技术公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 百时美施贵宝
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 诺华公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 百时美施贵宝公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 千年製药公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 新基公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • Kesios Therapeutics Limited
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 安基因公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 健赞公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 朱诺疗法
    • 公司简介
    • 产品介绍
    • 近期趋势

注意：在公司简介、财务细节、近期发展等方面，基于可用信息，私人控股公司可能不包括在内。

Product Code: VMR11216795

Multiple myeloma is a blood cancer similar to leukaemia and lymphoma that develops in the bone marrow. Certain white blood cells (WBCs) begin to grow inappropriately within the bone marrow in multiple myeloma. Different treatments are effective in delaying the disease's progression. Induction therapy is the first treatment for the condition. After that, stem cell transplantation (SCT) is performed. In stem cell transplantation, a machine extracts the patient's stem cells, which are then frozen and stored. Following that, the cells are implanted into the patient's body. Patients are also given chemotherapy, which includes administering medications like Adriamycin, Alkeran, Cytoxan, Oncovin, Pomalyst, Revlimid, Thalomid, and Velcade. Proteasome inhibitors are a common treatment for multiple myeloma and are used at all stages of the disease.

Market Dynamics:

The market for multiple myeloma medicines is predicted to develop as the disease's prevalence among the population rises. In addition, the growing elderly population across the globe will surely boost the market for multiple myeloma medicines. Furthermore, the market is expected to rise substantially due to the approval of newer treatments and the low efficacy of the currently available drugs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of multiple myeloma therapeutics. The growth and trends of multiple myeloma therapeutics industry provide a holistic approach to this study.

Market Segmentation:

This section of the multiple myeloma therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Chemotherapy
  • Radiation
  • Stem Cell Transplant
  • Other Supportive Treatments

By End Users/Applications

  • Hospitals
  • Clinics
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Multiple Myeloma Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the multiple myeloma therapeutics market include Janssen Biotech, Inc., Bristol-Myers Squibb, Novartis AG, Bristol-Myers Squibb Company, Millennium Pharmaceuticals, Celgene Corporation, Kesios Therapeutics Limited, Amgene, Inc., Genzyme Corporation, Juno Therapeutics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MULTIPLE MYELOMA THERAPEUTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Product Type
    • 3.7.2 By End Users
    • 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL MULTIPLE MYELOMA THERAPEUTICS MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Chemotherapy Market by Regions
  • 6.6 Radiation Market by Regions
  • 6.5 Stem Cell Transplant Market by Regions
  • 6.7 Other Supportive Treatments Market by Regions

7 . GLOBAL MULTIPLE MYELOMA THERAPEUTICS MARKET ANALYSIS BY END USERS

  • 7.1 Overview by End Users
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End Users
  • 7.4 Hospitals Market by Regions
  • 7.5 Clinics Market by Regions
  • 7.6 Others Market by Regions

8 . GLOBAL MULTIPLE MYELOMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview, Historic and Forecast Data
    • 8.3.2. North America By Segment
    • 8.3.3. North America By Country
    • 8.3.4. United State
    • 8.3.5. Canada
    • 8.3.6. Mexico
  • 8.4. Europe
    • 8.4.1. Overview, Historic and Forecast Data
    • 8.4.2. Europe by Segment
    • 8.4.3. Europe by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7. Italy
    • 8.4.8. Russia
    • 8.4.9. Rest Of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview, Historic and Forecast Data
    • 8.5.2. Asia Pacific by Segment
    • 8.5.3. Asia Pacific by Country
    • 8.5.4. China
    • 8.5.5. India
    • 8.5.6. Japan
    • 8.5.7. South Korea
    • 8.5.8. Australia
    • 8.5.9. Rest Of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview, Historic and Forecast Data
    • 8.6.2. Latin America by Segment
    • 8.6.3. Latin America by Country
    • 8.6.4. Brazil
    • 8.6.5. Argentina
    • 8.6.6. Peru
    • 8.6.7. Chile
    • 8.6.8. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview, Historic and Forecast Data
    • 8.7.2. Middle East & Africa by Segment
    • 8.7.3. Middle East & Africa by Country
    • 8.7.4. Saudi Arabia
    • 8.7.5. UAE
    • 8.7.6. Israel
    • 8.7.7. South Africa
    • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE MULTIPLE MYELOMA THERAPEUTICS COMPANIES

  • 9.1. Multiple Myeloma Therapeutics Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF MULTIPLE MYELOMA THERAPEUTICS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Janssen Biotech, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Bristol-Myers Squibb
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Novartis AG
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Bristol-Myers Squibb Company
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Millennium Pharmaceuticals
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Celgene Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Kesios Therapeutics Limited
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Amgene, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Genzyme Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Juno Therapeutics
    • 10.12.1. Company Overview
    • 10.12.2. Financials
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product Type (USD MN)
  • Chemotherapy Market by Geography (USD MN)
  • Radiation Market by Geography (USD MN)
  • Stem Cell Transplant Market by Geography (USD MN)
  • Other Supportive Treatments Market by Geography (USD MN)
  • Analysis Market by End Users (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Clinics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Multiple Myeloma Therapeutics Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Multiple Myeloma Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Multiple Myeloma Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by End Users
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Chemotherapy Market by Geography (USD MN)
  • Radiation Market by Geography (USD MN)
  • Stem Cell Transplant Market by Geography (USD MN)
  • Other Supportive Treatments Market by Geography (USD MN)
  • Global Market Analysis by End Users (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Clinics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.